TY - JOUR
T1 - Characterization of genetically engineered mouse hepatoma cells with inducible liver functions by overexpression of liver-enriched transcription factors
AU - Yamamoto, Hideaki
AU - Tonello, Jane Marie
AU - Sambuichi, Takanori
AU - Kawabe, Yoshinori
AU - Ito, Akira
AU - Kamihira, Masamichi
N1 - Funding Information:
This work was financially supported in part by Grants-in-Aid for Scientific Research (nos. 23650289 and 26560216 ) from the Japan Society for the Promotion of Science (JSPS) . Appendix A
Publisher Copyright:
© 2017 The Society for Biotechnology, Japan
PY - 2018/1
Y1 - 2018/1
N2 - New cell sources for the research and therapy of organ failure could significantly alleviate the shortage of donor livers that are available to patients who suffer from liver disease. Liver carcinoma derived cells, or hepatoma cells, are the ideal cells for developing bioartificial liver systems. Such cancerous liver cells are easy to prepare in large quantities and can be maintained over long periods under standard culture conditions, unlike primary hepatocytes. However, hepatoma cells possess only a fraction of the functions of primary hepatocytes. In a previous study, by transducing cells with liver-enriched transcription factors that could be inducibly overexpressed—hepatocyte nuclear factor (HNF)1α, HNF1β, HNF3β [FOXA2], HNF4α, HNF6, CCAAT/enhancer binding protein (C/EBP)α, C/EBPβ and C/EBPγ—we created mouse hepatoma cells with high liver-specific gene expression called the Hepa/8F5 cell line. In the present study, we performed functional and genetic analyses to characterize the Hepa/8F5 cell line. Further, in three-dimensional cultures, the function of these cells improved significantly compared to parental cells. Ultimately, these cells might become a new resource that can be used in basic and applied hepatic research.
AB - New cell sources for the research and therapy of organ failure could significantly alleviate the shortage of donor livers that are available to patients who suffer from liver disease. Liver carcinoma derived cells, or hepatoma cells, are the ideal cells for developing bioartificial liver systems. Such cancerous liver cells are easy to prepare in large quantities and can be maintained over long periods under standard culture conditions, unlike primary hepatocytes. However, hepatoma cells possess only a fraction of the functions of primary hepatocytes. In a previous study, by transducing cells with liver-enriched transcription factors that could be inducibly overexpressed—hepatocyte nuclear factor (HNF)1α, HNF1β, HNF3β [FOXA2], HNF4α, HNF6, CCAAT/enhancer binding protein (C/EBP)α, C/EBPβ and C/EBPγ—we created mouse hepatoma cells with high liver-specific gene expression called the Hepa/8F5 cell line. In the present study, we performed functional and genetic analyses to characterize the Hepa/8F5 cell line. Further, in three-dimensional cultures, the function of these cells improved significantly compared to parental cells. Ultimately, these cells might become a new resource that can be used in basic and applied hepatic research.
UR - http://www.scopus.com/inward/record.url?scp=85028343596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028343596&partnerID=8YFLogxK
U2 - 10.1016/j.jbiosc.2017.07.011
DO - 10.1016/j.jbiosc.2017.07.011
M3 - Article
C2 - 28847578
AN - SCOPUS:85028343596
VL - 125
SP - 131
EP - 139
JO - Journal of Bioscience and Bioengineering
JF - Journal of Bioscience and Bioengineering
SN - 1389-1723
IS - 1
ER -